Mosaic Health raises $45M to launch ClaraRX, an AI prescribing assistant for clinicians

AI · 5 min read

ClaraRX analyzes patient records, allergies, comorbidities, and local formulary availability to suggest evidence-based prescriptions with dosing options tailored to patient specifics. Mosaic Health said it built the assistant with clinician-in-the-loop workflows, providing clear rationales and citations for each suggestion.

The $45 million Series B will support additional clinical trials, expanded EHR integrations, and certification for use in multiple regulatory markets. Mosaic emphasized that ClaraRX operates as a decision-support tool and will not autonomously prescribe; audit logs and human sign-off are core parts of the workflow.

Initial pilots with regional hospital networks showed reduction in prescribing time and fewer formulary overrides. Mosaic plans to open a broader beta for primary care and urgent care clinicians later this quarter, while pursuing partnerships with pharmacy benefits managers for real-world cost optimization.